Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial

Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial

(1) Background: This study aimed to compare the immunogenicity of the mix-and-match CoronaVac/BNT162b2 vaccination to the homologous CoronaVac/CoronaVac regimen. (2) Methods: We conducted a simple-blinded randomized superiority trial to measure SARS-CoV-2 neutralization antibodies and anti-spike rec...

Full description

Bibliographic Details
Main Authors: Samar Samoud, Jihene Bettaieb, Mariem Gdoura, Ghassen Kharroubi, Feriel Ben Ghachem, Imen Zamali, Ahlem Ben Hmid, Sadok Salem, Ahmed Adel Gereisha, Mongi Dellagi, Nahed Hogga, Adel Gharbi, Amor Baccouche, Manel Gharbi, Chadha Khemissi, Ghada Akili, Wissem Slama, Nabila Chaieb, Yousr Galai, Hechmi Louzir, Henda Triki, Melika Ben Ahmed
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Vaccines
Subjects:
COVID-19
BNT162b2
CoronaVac
immunogenicity
tolerance
Online Access:https://www.mdpi.com/2076-393X/11/8/1329

Internet

https://www.mdpi.com/2076-393X/11/8/1329

Similar Items